Norges Bank Kala Pharmaceuticals, Inc. Transaction History

Norges Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 23, 2018	SELL	$13.3 - $17.49 $1.22 Million - $1.61 Million	-91,866 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$12.26 - $18.98 $1.13 Million - $1.74 Million	91,866 New	91,866 $1.45 Million
Q1 2018 May 09, 2018	SELL	$12.26 - $18.98 $1.13 Million - $1.74 Million	-91,866 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$13.68 - $23.17 $1.26 Million - $2.13 Million	91,866 New	91,866 $1.7 Million
Q4 2017 Feb 09, 2018	SELL	$13.68 - $23.17 $478,800 - $810,950	-35,000 Closed	0 $0
Q3 2017 Nov 13, 2018	BUY	$19.86 - $26.53 $695,100 - $928,550	35,000	35,000 $799,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $7.83M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.